Chronic Myeloid Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
Treatment of chronic phase chronic myeloid leukemia may include: targeted therapy (asciminib, imatinib mesylate, nilotinib, dasatinib, bosutinib)
targeted therapy continues to be the mainstay of chronic phase treatment in most patients with chronic myeloid leukemia.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice
- Milestones in Chronic Lymphocytic Leukemia
- Trial Results Show Majority of Patients With CLL Achieve uMRD With VenO
- On the architecture of translational research designed to control chronic lymphocytic leukemia
- Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)